NHS cleared to use Astellas' non-hormonal menopause drug
Around half a million women will soon be able to access Astellas' Veoza treatment for symptoms like hot flushes associated with menopause.
Newsletters and Deep Dive digital magazine
Around half a million women will soon be able to access Astellas' Veoza treatment for symptoms like hot flushes associated with menopause.
Genmab's recently approved therapy for relapsed cervical cancer has been turned down for NHS use in initial NICE guidance.
The FDA stops short of approving leucovorin for autism, but will its clearance for ultra-rare condition CFD-FOLR1 lead to more off-label prescribing?
The FDA has issued additional guidance that aims to make it easier for drugmakers to bring biosimilars of patent-expired biologic drugs to market.
Incyte claims EU approval for Zynyz as the first systemic therapy for anal cancer, as J&J gets the nod for wider use of Akeega in prostate cancer.
Editor's Picks
Newsletters and Deep Dive
digital magazine